ผศ.(พิเศษ) พญ.สาริน กิจพาณิชย์
Radiation Oncologist
Division of Radiation Oncology, King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand
ABOUT DR. SARIN KITPANIT
Dr. Sarin Kitpanit is a graduate of the Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand where she completed her radiation oncology residency in 2017. She attended Memorial Sloan Kettering Cancer Center, New York, USA as a research fellow in 2019-2020. Her practice and research focus on proton therapy and advanced radiation treatment, including IMRT/VMAT, stereotactic radiosurgery, and stereotactic radiotherapy (SRS/SRT), especially in head and neck cancers, tumors, upper gastrointestinal cancer, and reirradiation. She has pioneered proton therapy for head and neck cancers at HPSP. Dr. Kitpanit currently serves as a secretary of the educational committee of The Federation of Asian Organizations for Radiation Oncology (FARO) and a committee of the Thai Association of Radiation Oncology (THASTRO).
ประวัติ
Undergraduate education
- 2012 Doctor of Medicine, Faculty of Medicine, Chulalongkorn University
Postgraduate training
- 2017 Board certification, Thai board of Radiation Oncology
- 2020 Certificate, Fellowship in Proton therapy and Head and neck services, Memorial Sloan Kettering Cancer Center, New York, USA
- 2017 – Present Attending, Division of Radiation Oncology, King Chulalongkorn Memorial Hospital, Thai Red Cross Society
- 2022: Honorary speaker, “Proton therapy in Head and Neck Cancers: ASEAN experience”, Association of Radiation Oncologists of India (AROI) 42nd annual meeting, New Delhi, India
- 2022: Invited speaker, “Basic Knowledge of Radiation Oncology and Clinical Care”, 2022 Basic Science Course, The Royal College of Otolaryngologists-Head and Neck Surgeons of Thailand (RCOT)
- 2022: Head and NEck Cancer subcommittee, National Health Security Office
- 2021: Invited speaker, “ASTRO and ESTRO highlights”, Thai Association of Radiation Oncology (THASTRO) 2021 annual meeting.
- 2021: Invited speaker, “Nasopharyngeal Cancer”, Thai Association of Radiation Oncology (THASTRO) 2021 Refresher Course.
- 2018: Travel grant, Federation of Asian Organizations for Radiation Oncology (FARO) 3rd annual meeting, Bali, Indonesia
- 2018: Invited speaker, “Esophageal and gastric cancer”, Thai Association of Radiation Oncology (THASTRO) 2021 annual meeting.
- 2017: Observership, Division of Radiation Oncology, OncoRay, Carl Gustav Carus University Hospital, Dresden, Germany
Temporal Lobe Necrosis in Head and Neck Cancer Patients after Proton Therapy to the Skull Base
Kitpanit S, Lee A, Pitter KL, Fan D, Chow CHJ, Neal B et al. Int J Part Ther. 2020;6(4):17–28.
DOI: https://doi.org/10.14338/IJPT-20-00014.1
Toxicity Profiles and Survival Outcomes Among Patients with Non-Metastatic Nasopharyngeal Carcinoma Treated with Intensity-Modulated Proton Therapy (IMPT) versus Intensity-Modulated Radiation Therapy (IMRT).
Li X, Kitpanit S, Lee A, Sherman E, Dunn L, Michel L, et al. JAMA Netw Open. 2021;4(6):e2113205.
DOI: https://doi.org/10.1001/jamanetworkopen.2021.13205
Evaluation of Proton Therapy Reirradiation for Patients With Recurrent Head and Neck Squamous Cell Carcinoma.
Lee A, Woods R, Mahfouz A, Kitpanit S, Cartano O, Mohamed N et al. JAMA Netw Open. 2023;6(1):e2250607. doi:10.1001/jamanetworkopen.2022.50607
Osteoradionecrosis of the Jaw Following Proton Radiation Therapy for Patients With Head and Neck Cancer.
Singh A, Kitpanit S, Neal B, Yorke E, White C, et al.
JAMA Otolaryngol Head Neck Surg. 2023;149(2):151–159. doi:10.1001/jamaoto.2022.4165
Comparison between the seventh and eighth edition of the AJCC/UICC staging system for nasopharyngeal cancer integrated with pretreatment plasma Epstein-Barr virus DNA level in a non-Chinese population: secondary analysis from a prospective randomized trial.
Kitpanit S, Jittapiromsak N, Sriyook A, Prayongrat A, Kannarunimit D, Chakkabat C, Lertbutsayanukul C. Jpn J Clin Oncol. 2019 Dec 27;49(12):1100-1113.
DOI: https://doi.org/10.1093/jjco/hyz109
Cranial neuropathies in advanced nasopharyngeal carcinoma: Neurological recovery after modern radiotherapy and systemic chemotherapy
Chow JCH, Lee A, Bao KKH, Cheung KM, Chan JCH, Tam AHP, Sung WWY, Tsui TYM, Chuk EYH, Chung DHS, Wong KH, Prayongrat A, Lertbutsayanukul C, Kannarunimit D, Chakkabat C, Kitpanit S. Radiother Oncol. 2021 Oct;163:221-228. doi: 10.1016/j.radonc.2021.08.022.
Outcomes and toxicities of definitive radiotherapy and reirradiation using 3-dimensional conformal or intensity-modulated (pencil beam) proton therapy for patients with nasal cavity and paranasal sinus malignancies.
Fan M, Kang JJ, Lee A, Fan D, Wang H, Kitpanit S, et al. Cancer. 2020 Jan 1;126(9):1905-1916.
DOI: https://doi.org/10.1002/cncr.32776
Any Day, Split Halfway: Flexibility in Scheduling High‐Dose Cisplatin‐‐A large retrospective review from a high‐volume cancer center.
Kang JJ, Tchekmedyian V, Mohammed N, Rybkin A, Kitpanit S, Fan M, et al. Int J Cancer. 2021 Jul 1;149(1):139-148.
DOI: https://doi.org/10.1002/ijc.33518
Oonsiri S, Kitpanit S, Kannarunimit D, Chakkabat C, Lertbutsayanukul C, Prayongrat A. Phys Imaging Radiat Oncol. 2022 Apr 28;22:51-56.
DOI: 10.1016/j.phro.2022.04.005
Intarak S, Chongpison Y, Vimolnoch M, Oonsiri S, Kitpanit S, Prayongrat A, et al. Front Oncol. 2022 Jan 28;12:775248. DOI: 10.3389/fonc.2022.775248
The effect of short radiation treatment breaks on chemo-radiotherapy for oropharyngeal cancers.
Rybkin A, Kang JJ, Lee A, Kitpanit S, Fan M, Mohamed N, et al. Head Neck. 2021 Dec;43(12):3796-3809.
DOI: 10.1002/hed.26879
Clinical Outcomes and Toxicities in Oropharyngeal Cancer (OPC) Patients Treated with Proton Therapy: A Single Institutional Experience.
S. Kitpanit, A. Lee, D. Fan, M. Fan, H. Wang, D. Gelblum et al. Int J Radiat Oncol Biol Phys. 2020 April 1;106(5):1152-1153.